Mitochondrial diseases: Molecular mechanisms, clinical presentations and diagnosis investigations;Les maladies mitochondriales: Mécanismes moléculaires, principaux cadres cliniques et approches diagnostiques

Annales de Pathologie

Volumn 25, Issue 4, 2005, Pages 270-281

  Auré, Karine ^a   Jardel, Claude ^a   Lombès, Anne ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Mitochondrial diseases; Mitochondrial DNA; Oxidative phosphorylation; Respiratory chain

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFECT; FAMILY HISTORY; GENE MUTATION; HUMAN; INHERITANCE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MORPHOLOGY; MUSCLE TISSUE; NEUROIMAGING; RESPIRATORY CHAIN; REVIEW; SYMPTOMATOLOGY; SYSTEMIC DISEASE;

EID: 27944499261     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(05)80131-2     Document Type: Review

References (65)

1. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J Clin Invest 1962; 41: 1776-804.
2. Olson W, King Engel W, Walsh GO, Einaugler R. Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol 1972; 26: 193-211.
3. Capaldi RA, Halphen DG, Zhang YZ, Yanamura W. Complexity and tissue specificity of the mitochondrial respiratory chain. J Bioenerg Biomembr 1988; 20: 291-311.
4. Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation. Nature 1967; 213: 137-9.
5. Anderson S, Bankier AT, Barrel BG, De Bruijn MHL, Coulson AR, Drouin J et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
6. Brown WM, George M, Wilson AC. Rapid evolution of animal mtDNA. Proc Natl Acad Sci USA 1979; 76: 1967-71.
7. DiMauro S, Andreu AL. Mutations in mtDNA: are we scrapping the bottom of the Barrel? Brain Pathology 2000; 10: 431-41.
8. Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani M, Mariotti C, et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004; 364: 592-6.
9. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998; 121: 1889-94.
10. Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48: 188-93.
11. Munnich A, Rustin P, Rötig A, Chretien D, Bonnefont JP, Nuttin C, et al. Clinical aspects of mitochondrial disorders. J Inher Metab Dis 1992; 15: 448-55.
12. Fayet G, Jansson M, Sternberg D, Moslemi AR, Blondy P, Lombes A et al. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromuscul Disord 2002; 12: 484-93.
13. Possekel S, Lombès A, Ogier de Baulny H, Cheval MA, Fardeau M, Kadenbach B, et al. Immunohistochemical analysis of muscle cytochrome c oxidase deficiency in children. Histochemistry 1995; 103: 59-68.
14. Pavlakis SG, Phillips PC, DiMauro S, DeVivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
15. Kobayashi Y, Momoi MY, Tominaga K, Momoi T, Nihei K, Yanagisawa M et al. A point mutation in the mitochondrial tRNAleu(UUR) gene in MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis and Stroke-like episodes). Biochem Biophys Res Comm 1990; 173: 816-22.
16. Goto Y, Nonaka I, Horai S. A mutation in the tRNA-Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
17. Tarnopolsky MA, Maguire J, Myint T, Applegarth D, Robinson BH. Clinical, physiological, and histological features in a kindred with the T3271C Melas mutation. Muscle Nerve 1998; 21: 25-33.
18. Penisson-Besnier I, Reynier P, Asfar P, Douay O, Sortais A, Dubas F, et al. Recurrent brain hematomas in MELAS associated with an ND5 gene mitochondrial mutation. Neurology 2000; 55: 317-8.
19. Bataillard M, Chatzoglou E, Rumbach L, Sternberg D, Tournade A, Laforet P, et al. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 2001; 56: 405-7.
20. Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001; 134: 721-8.
21. Laforêt P, Ziegler F, Sternberg D, Rouche A, Frachon P, Fardeau M, et al. Mutation «MELAS» (A3243G) de l'ADN mitochondrial: étude chez 19 patients des relations entre le phénotype clinique, les données morphologiques et moléculaires. Rev Neurol (Paris) 2000; 156: 1136-47.
22. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease entity or a syndrome? J Neurol Sci 1980; 47: 117-133.
23. Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNAlys mutation. Cell 1990; 61: 931-7.
24. Verma A, Moraes CT, Shebert RT, Bradley WG. A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology 1996; 46: 1334-6.
25. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol (Chicago) 1958; 60: 280.
26. Rowland LP. Progressive external ophthalmoplegia. In: Vinken PJ, Bruyn GW, DeJong JMBV, eds. Handbook of clinical neurology. Part 11: System disorders and atrophies. New York: American Elsevier Publishing Company, 1975: 177-202.
27. Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1988; i: 885.
28. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
29. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38: 1339-46.
30. Moraes CT, DiMauro S, Zeviani M, Lombès A, Shanske S, Miranda A, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
31. Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S, D'Agati V. Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 1994; 45: 1388-96.
32. Pearson HA, Lobel JS, Kocoshis SA, Naiman JW, Windmuller J, Lammi AT et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatrics 1979; 95: 976-84.
33. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-33.
34. DeVries DD, Van Engelen BGM, Gabreëls FJM, Ruitenbeek W, Van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993; 34: 410-2.
35. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurochem 1951; 14: 216-21.
36. Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome [see comments]. Am J Hum Genet 1998; 63: 1598-608.
37. Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, Sengers RC, et al. Isolated complex 1 deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000; 15: 123-34.
38. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-P, Quignot E, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 1995; 11: 144-9.
39. Parfait B, Chretien D, Rotig A, Marsac C, Munnich A, Rustin P. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex Il in a patient with Leigh syndrome. Hum Genet 2000; 106: 236-43.
40. Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet 1998; 20: 337-43.
41. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998; 63: 1609-21.
42. Valnot I, von Kleist-Retzow JC, Barrientos A, Gorbatyuk M, Taanman JW, Mehaye B, et al. A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Mol Genet 2000; 9: 1245-9.
43. Hirano M, Silvestri G, Blake DM, Lombès A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.
44. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-92.
45. Erickson RP. Leber's optic atrophy, a possible example of maternal inheritance. Am J Hum Genet 1972; 24: 348-9.
46. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-30.
47. Singh G, Lott MT, Wallace DC. A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy. New England Journal of Medicine 1989; 320: 1300-5.
48. Lott MT, Voljavec AS, Wallace DC. Variable genotype of Leber's hereditary optic neuropathy patients. Am J Ophthalmol 1990; 109: 625-31.
49. Johns DR, Neufeld MJ. Cytochrome b mutations in Leber hereditary optic neuropathy. Biochem. Biophys Res Comm 1991; 181: 1358-64.
50. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994; 91: 6206-10.
51. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337: 508-10.
52. Nolan D, Hammond E, James I, McKinnon E, Mallal S. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir Ther 2003; 8: 617-26.
53. Dagan T, Sable C, Bray J, Gerschenson M. Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? Mitochondrion 2002.
54. Vittecoq D, Jardel C, Barthélémy C, Escaut L, Cheminot N, Chapin S, et al. Mitochondrial damage associated with long-term antiretroviral treatment: associated alteration or causal disorder? J Acquir Immune Defic Syndr 2002; 31: 299-308.
55. McComsey G. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy. AIDS Rev 2002; 4: 140-7.
56. Chou SM. «Megaconial» mitochondria observed in a case of chronic polymyositis. Acta Neuropathol (Berl) 1968; 12: 68-89.
57. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003; 557: 491-501.
58. Odievre MH, Lombes A, Dessemme P, Santer R, Brivet M, Chevallier B, et al. A secondary respiratory chain defect in a patient with Fanconi-Bickel syndrome. J Inherit Metab Dis 2002; 25: 379-84.
59. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 2004; 14: 237-45.
60. Touati G, Rigal O, Lombès A, Frachon P, Giraud M, Ogier de Baulny H. In vivo functional investigations of lactic acid in patients with respiratory chain disorders. Arch Dis Child 1997; 76: 16-21.
61. Romero NB, Lombès A, Touati G, Rigal O, Frachon P, Cheval MA et al. Morphological studies of skeletal muscle in lactic acidosis. J Inher Metab Dis 1996; 19: 528-34.
62. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51.
63. Kogelnik AM, Lott MT, Brown MD, Navathe SB, Wallace DC. MITOMAP: an update on the status of the human mitochondrial genome database. Nucl Acids Res 1997; 25: 196-9.
64. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989; 246: 500-3.
65. Darin N, Moslemi AR, Lebon S, Rustin P, Holme E, Oldfors A, et al. Genotypes and clinical phenotypes in children with cytochrome-c oxidase deficiency. Neuropediatrics 2003; 34: 311-7.